News

Vitamin K: A little-known but noteworthy nutrient

Kyla Shea
By Kyla Shea
January 23, 2021

When Danish scientist Henrik Dam fed a cholesterol-free diet to baby chicks in his lab about 90 years ago, he noticed excessive bleeding in some of them. It did not stop after he replaced the cholesterol. Dam ultimately concluded the bleeding was related to a "depletion of an anti-hemorrhagic compound," which he called vitamin K (for "koagulation," as spelled in Danish). For that discovery, Dam won the Nobel Prize in Physiology or Medicine in 1943.

Vitamin-K-445x297.jpg
Many plant-based foods are high in vitamin K.

Most people know about vitamins A, B, C, D and/or E, but vitamin K slips under the nutritional radar. Yet it is essential for life because it's required for blood to clot normally. Now scientists are now realizing there is more to know about this less appreciated nutrient.

Today, the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University houses the only research team in the world focused exclusively on vitamin K nutrition. I am a research scientist on that team. We study how food provides vitamin K to support healthy aging.

Why is vitamin K important?

Over the past few decades, scientists discovered vitamin K-dependent proteins in many tissues throughout the body. This suggests vitamin K has physiological roles well beyond blood clotting. For example, in arterial tissue, proteins dependent on vitamin K can help prevent calcification. This is critical, because arterial calcification can lead to heart attacks.

Without vitamin K, these proteins cannot prevent calcification. And because these proteins are present in cartilage and bone, we are also studying how these vitamin K-dependent proteins may be involved in osteoarthritis.

Just as there are several forms of B vitamins, there are also multiple forms of vitamin K. Scientists know of at least 12. Phylloquinone, also known as vitamin K1, is synthesized by plants. Green leafy vegetables, like spinach and collard greens, and vegetable oils, like soybean and canola oil, contain high amounts of phylloquinone.

Menaquinones, a class of vitamin K compounds also known as vitamin K2, are found in variable amounts in animal-based foods, such as dairy foods and some meats. Menaquinones are also produced by intestinal microbiota, although their nutritional value is uncertain.

Our lab has measured the amount of vitamin K in thousands of foods commonly consumed in North America. In partnership with the U.S. Department of Agriculture, this information is publicly available at the USDA's Food Data Central website, the most comprehensive nutrition database in the world. Over 350,000 foods are profiled.

What's next?

A goal of our research is to establish a recommended dietary allowance for vitamin K. In North America, current dietary recommendations for vitamin K are referred to as "adequate intake," the amount assumed to ensure nutritional adequacy. An adequate intake is set when insufficient scientific evidence exists to provide a more precise recommended dietary allowance. For men over 18, the adequate intake for vitamin K is 120 micrograms a day. For women, it is 90 micrograms a day. One cup of raw spinach contains 145 micrograms of phylloquinone. Patients who are taking warfarin need to consult with their healthcare professional for guidance on their vitamin K intakes.

Vitamin-K-greens-445x363.jpg
Dark green leafy vegetables, like kale, are high in vitamin K.

Clotting abnormalities due to low dietary vitamin K intakes are extremely rare because nearly everyone consumes enough vitamin K in his or her diet to maintain normal coagulation. Although emerging evidence suggests low vitamin K intakes may influence health outcomes unrelated to coagulation, right now this evidence does not support the need to take vitamin K supplements, even though they are on the market. Menaquinone supplements have become particularly popular because there are claims they have unique health benefits that phylloquinone does not.

However it is very difficult to isolate the effect of a nutrient on a health outcome, and even more difficult to recommend supplement use based on the studies that have been done to date. Large clinical trials must be designed to address the question. These trials, which can cost millions, have not yet been conducted with vitamin K. The smaller trials that have been done do not meet the standards of scientific rigor required to promote vitamin K supplements at this time.

As our research continues, we strive for a better understanding of vitamin K's role in human health beyond coagulation. We want to know how much vitamin K is needed to protect against age-related disease and disability. However, until we have more robust evidence that supplements are needed, it is safer, and more enjoyable, to obtain vitamin K from food.

Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author and do not necessarily reflect the views of the USDA.The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Kyla Shea
Kyla Shea

Kyla Shea is a scientist on the vitamin K team at the USDA Human Nutrition Research Center on Aging at Tufts University. Her research focuses on the role of micronutrients in age-related disease and disability, with an emphasis on vitamin K.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Branon works to break barriers in science and higher education
ASBMB Annual Meeting

Branon works to break barriers in science and higher education

March 03, 2021

Tess Branon will speak on proximity-dependent biotinylation during the Molecular & Cellular Proteomics early-career researcher session at the 2021 ASBMB Annual Meeting.

Brain Injury Awareness Month 2021
Health Observance

Brain Injury Awareness Month 2021

March 01, 2021

In the U.S., about 2.8 million people sustain a traumatic brain injury annually. Learn about recent research on TBI-related dementia, dysfunctional mitochondria and other work powering the march toward better therapies.

The evolution of proteins from mysteries to medicines
Essay

The evolution of proteins from mysteries to medicines

February 27, 2021

An essay in observance of National Protein Day.

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Progeria: From the unknown to the first FDA-approved treatment
Health Observance

Progeria: From the unknown to the first FDA-approved treatment

February 25, 2021

Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.